Immune Intelligence Unlocked.

Our AI deciphers the immune system for improved patient outcomes.

landing_page_hero

Antibody Discovery & De-Risking

Therapeutic antibodies are raised in animals or on display platforms and then engineered to work in humans. AbSapien instead retrieves antibodies that were already selected inside healthy people, before immunogenicity and developability liabilities are built in.

Discover More
Target_Identification_image

Response Prediction

Leverage the intelligence of the immune system to predict which patients will respond to which therapies in cancer and autoimmune diseases. Optimize your clinical trials and patient access to your 2L/3L treatments.

Discover More
Response_Prediction_image

Biomarker Development

Translate immune repertoire data into powerful biomarkers for diagnostics and clinical endpoints. Our AI decodes the complexity of the immune system to build highly predictive CDx for oncology, infectious, and autoimmune diseases.

Discover More
Biomarker_Development_image

Supported By

Excellent Accelerator Programs


accelerators

Tailored Solutions

Accelerating discovery and development for every stage of the pipeline.

Biotech

For Biotech

Unlock novel targets directly from human immunology. MyImmune's AI maps epitope-specific antibody clusters with >95% purity.

Learn More →
pharmacy-symbol

For Pharma

De-risk clinical trials with AI Patient Stratification. Decode adaptive immune responses to predict immunotherapy outcomes.

Learn More →
patient-file

For CROs

Translate immune repertoire data into powerful biomarkers. Build highly predictive CDx for oncology and infectious diseases.

Learn More →

Scientific Capabilities

Disease Detection

MyImmune leverages paratope networks to accurately detect diseases and identify therapeutic cells for precision medicine.

Read Paper →

Antibody Clustering

By clustering CDR sequences, MyImmune identifies antigen-specific antibodies to speed up therapeutic development.

Read Paper →

Immunotherapy responses

This review explains how immune-receptor sequencing plus machine learning can help predict patient responses to immunotherapy.

Read Paper →

Led by pioneers in Computational Immunology and AI.

Our team combines world-class scientific expertise with business acumen to build trust and deliver results.

Ayan Sengupta

Ayan Sengupta

Co-Founder & CEO

Prof Daron Standley, PhD

Prof Daron Standley, PhD

Co-Founder & CSA

Songling Li, PhD

Songling Li, PhD

Founding Scientist

Debottam Upadhyaya

Debottam Upadhyaya

Lead Fullstack Engineer

Guy Cavet, PhD

Guy Cavet, PhD

Board of Directors

Maximilian Schmid, MD

Maximilian Schmid, MD

Board of Advisors

Mara Anais Llamas, PhD

Mara Anais Llamas, PhD

Scientist

Clara Vasquez

Clara Vasquez

Scientist

Ready to decode the immune system?

Get in touch to leverage the full potential of the adaptive immune repertoire